前列腺癌生化复发患者[18F]DCFPyL PET/CT全身肿瘤负荷与肿瘤生物学及PSA动力学的关联
本研究纳入275例根治性治疗后生化复发的前列腺癌患者,用aPROMISE软件分析[18F]DCFPyL PET/CT的分子影像变量与临床及PSA变量的关联。结果显示,PSA水平、PSA动力学及ISUP分级分组5与全身肿瘤负荷变量显著相关,PSA和PSAvel的截断值(1.15 ng/ml和0.065 ng/ml/月)与PET/CT阳性显著相关。
要点
- PSA水平、PSA动力学和ISUP分级分组5是[18F]DCFPyL PET/CT上较大肿瘤负荷变量的稳健预测变量。
- PSA>2ng/ml、PSAdt≤6个月和PSAvel≥0.2ng/ml/月组的平均wbTV、wbTLA和wbPSMA值显著更高。
- PSA截断值1.15 ng/ml和PSAvel截断值0.065 ng/ml/月与PET/CT阳性显著相关。
核心结论
- 较高的PSA值、不利的PSA动力学和ISUP分级分组5是[18F]DCFPyL PET/CT上较大肿瘤负荷变量的稳健预测变量。
研究设计与样本
- 分析根治性治疗后生化复发的前列腺癌患者,获取临床和PSA变量,所有PET/CT扫描用aPROMISE软件回顾,对阳性扫描进行病灶分割,获得SUV衍生变量、肿瘤负荷变量和miTNM分期,采用ANOVA、Kruskal-Wallis和Spearman相关检验分析关联,并进行多变量分析。
- 共研究275例患者,[18F]DCFPyL-PET/CT在165/275例患者中为阳性。
主要发现
- 多变量分析中,生化复发时刻、ISUP分组、PSA水平和PSAvel与检出率显著相关。
- miTNM与PSA水平(p<0.001)和动力学(p<0.001)显著相关,在转移性疾病患者中更高。
- PSA和PSAvel均与wbTV、wbTLA和wbPSMA呈中度相关(p<0.001),与SUV呈弱相关。
- 平均wbTV、wbTLA和wbPSMA值在PSA>2ng/ml、PSAdt≤6个月和PSAvel≥0.2ng/ml/月组中显著更高。
- wbTV(p=0.039)和wbPSMA(p=0.020)在ISUP分级分组5患者中显著更高。
关键数值与推荐
- PSA截断值1.15 ng/ml与PET/CT阳性显著相关。
- PSAvel截断值0.065 ng/ml/月与PET/CT阳性显著相关。
- PSA>2ng/ml、PSAdt≤6个月和PSAvel≥0.2ng/ml/月组的平均wbTV、wbTLA和wbPSMA值显著更高。
- ISUP分级分组5患者的wbTV(p=0.039)和wbPSMA(p=0.020)显著更高。
- miTNM与PSA水平(p<0.001)和动力学(p<0.001)显著相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The objective was to assess the association between molecular imaging (mi) variables on [18F]DCFPyL-PET/CT with clinical and disease characteristics and prostate specific antigen (PSA) related variables in patients with biochemical recurrence of prostate cancer (BRPC). MATERIAL AND METHODS: We analysed patients with BRPC after radical treatment. We obtained clinical and PSA variables: International Society of Urology Pathology (ISUP) grade group, European Association of Urology (EAU) risk classification, PSA (PSA≤1ng/ml, 1<PSA≤2, PSA>2), PSA doubling time (PSAdt) and PSA velocity (PSAvel). All PET/CT scans were reviewed with the assistance of automated Prostate Molecular Imaging Standardized Evaluation (aPROMISE) software and lesions' segmentation in positive scans was performed using this platform. Standardized uptake value (SUV) derived variables; tumour burden variables [whole-body tumour volume (wbTV), whole-body tumour lesion activity (wbTLA) and whole-body mi PSMA (wbPSMA)] and miTNM staging were obtained. Cut-off of PSA and kinetics able to predict PET/CT results were obtained. Associations between disease and mi variables were analysed using ANOVA, Kruskal-Wallis and Spearman's correlation tests. Multivariate analysis was also performed. RESULTS: Two hundred and seventy-five patients were studied. [18F]DCFPyL-PET/CT were positive in 165/275 patients. In multivariate analysis, moment of biochemical recurrence, ISUP group, PSA level and PSAvel showed significant association with the detection rate. miTNM showed significant association with PSA level (p<0.001) and kinetics (p<0.001), being higher in patients with metastatic disease. Both PSA and PSAvel showed moderate correlation with wbTV, wbTLA and wbPSMA (p<0.001). A weak correlation with SUVs was found. Mean wbTV, wbTLA and wbPSMA values were significantly higher in PSA > 2ng/ml, PSAdt ≤ 6 months and PSAvel ≥ 0.2ng/ml/month groups. Also, wbTV (p=0.039) and wbPSMA (p=0.020) were significantly higher in patients with ISUP grade group 5. PSA and PSAvel cut-offs (1.15 ng/ml and 0.065 ng/ml/month) were significantly associated with a positive PET/CT. CONCLUSION: Higher PSA values, unfavourable PSA kinetics and ISUP grade group 5 were robust predictive variables of larger tumour burden variables on [18F]DCFPyL PET/CT assessed by aPROMISE platform.
引用
- García-Zoghby L, Amo-Salas M, Soriano Castrejón ÁM, et al. Whole-body tumour burden on [18F]DCFPyL PET/CT in biochemical recurrence of prostate cancer: association with tumour biology and PSA kinetics. Eur J Nucl Med Mol Imaging. 2024. PMID: 38520513. doi:10.1007/s00259-024-06685-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。